Wells Fargo & Company »

Gt Biopharma shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Gt Biopharma shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $77k 301k 0.26
2023-09-30 $73k 301k 0.24
2023-06-30 $32k 101k 0.31
2022-12-31 $89k 101k 0.89
2022-09-30 $0 546 0.00
2022-06-30 $1.5k 590 2.50
2022-03-31 $87k 30k 2.88
2021-12-31 $32k 11k 3.03
2021-09-30 $0 1.8k 0.00
2021-06-30 $6.0k 400 15.00
2021-03-31 $1.0k 119 8.40